Research Groups and R&D Platforms: Clinical development, Diabetes, Preclinical development
Research Group:
Incretin-based therapy in preclinical and early clinical type 1 diabetes
Jorma Toppari
jorma.toppari[at]utu.fi
Institute of Biomedicine,
University of Turku
Department of Pediatrics,
Turku University Hospital
Clinical development, Diabetes, Preclinical development
R&D Platform:
Turku PET Centre
Turku PET Centre is a Finnish National Research Institute for the use of short-lived positron emitting isotopes in the field of medical research.
The scientific research strategy of the Turku PET Centre involves six major topics: Cardiovascular and Metabolic research, Brain research, Cancer research, Preclinical studies and Drug development, Radiochemistry research and Data processing and image analysis.
Collaboration between academia and industry is also active. The studies are carried out together with basic scientists, dedicated physicists and radiochemists, experienced clinical investigators and other professionals.
Cancer, Cardiovascular diseases, Clinical development, Diabetes, In Vivo Diagnostics, Obesity, PET, Preclinical development
